These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 22031903

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. GFAP hyperpalmitoylation exacerbates astrogliosis and neurodegenerative pathology in PPT1-deficient mice.
    Yuan W, Lu L, Rao M, Huang Y, Liu CE, Liu S, Zhao Y, Liu H, Zhu J, Chao T, Wu C, Ren J, Lv L, Li W, Qi S, Liang Y, Yue S, Gao J, Zhang Z, Kong E.
    Proc Natl Acad Sci U S A; 2021 Mar 30; 118(13):. PubMed ID: 33753498
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotection and lifespan extension in Ppt1(-/-) mice by NtBuHA: therapeutic implications for INCL.
    Sarkar C, Chandra G, Peng S, Zhang Z, Liu A, Mukherjee AB.
    Nat Neurosci; 2013 Nov 30; 16(11):1608-17. PubMed ID: 24056696
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of neurodegeneration in a mouse model of infantile batten disease by magnetic resonance imaging and magnetic resonance spectroscopy.
    Munasinghe J, Zhang Z, Kong E, Heffer A, Mukherjee AB.
    Neurodegener Dis; 2012 Nov 30; 9(4):159-69. PubMed ID: 22327870
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered glutamate receptor function in the cerebellum of the Ppt1-/- mouse, a murine model of infantile neuronal ceroid lipofuscinosis.
    Finn R, Kovács AD, Pearce DA.
    J Neurosci Res; 2012 Feb 30; 90(2):367-75. PubMed ID: 21971706
    [Abstract] [Full Text] [Related]

  • 15. An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis.
    Macauley SL, Wong AM, Shyng C, Augner DP, Dearborn JT, Pearse Y, Roberts MS, Fowler SC, Cooper JD, Watterson DM, Sands MS.
    J Neurosci; 2014 Sep 24; 34(39):13077-82. PubMed ID: 25253854
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.
    Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, Griffey MA, Wong M, Sands MS, Cooper JD.
    Neurobiol Dis; 2007 Jan 24; 25(1):150-62. PubMed ID: 17046272
    [Abstract] [Full Text] [Related]

  • 19. Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response.
    Qiao X, Lu JY, Hofmann SL.
    BMC Neurosci; 2007 Nov 16; 8():95. PubMed ID: 18021406
    [Abstract] [Full Text] [Related]

  • 20. Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis.
    Bible E, Gupta P, Hofmann SL, Cooper JD.
    Neurobiol Dis; 2004 Jul 16; 16(2):346-59. PubMed ID: 15193291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.